Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CT-0508
i
Other names:
CT-0508, Ad5f35-transduced anti-HER2 CAR-M, CARMA-0508, HER2 targeted autologous CAR macrophage, CT-0285
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
CARISMA Therap
Drug class:
HER2 inhibitor, Macrophage stimulant
Related drugs:
‹
trastuzumab (407)
afatinib (227)
lapatinib (107)
neratinib (102)
pyrotinib (79)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
mobocertinib (12)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
inetetamab (6)
ASLAN001 (6)
BDTX-189 (5)
AEE788 (4)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
MET306 (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
sunvozertinib (3)
AST-301 (2)
Bay846 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
sevabertinib (1)
IAH0968 (1)
MP0274 (1)
Paletan (pertuzumab biosimilar) (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
RT1978 (1)
ABL105 (1)
RG6596 (1)
KD019 (1)
IMM2902 (1)
ABT-101 (0)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
BMS690514 (0)
CAM-H2 (0)
CAT-179 (0)
CUDC-101 (0)
DA 3111 (trastuzumab biosimilar) (0)
EG1206A (pertuzumab biosimilar) (0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
Faceptor (trastuzumab biosimilar) (0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
JNJ-26483327 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MP412 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
SYSA1901 (pertuzumab biosimilar) (0)
Sym013 (0)
TAC100-HER2 (0)
TAK-285 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
AST1306 (0)
cipatinib (0)
dHER2+AS15 (0)
IBI315 (0)
KBP-5209 (0)
RG6194 (0)
AZD8931 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
mifamurtide (2)
RB-1355 (0)
LOAd703 (0)
trastuzumab (407)
afatinib (227)
lapatinib (107)
neratinib (102)
pyrotinib (79)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
mobocertinib (12)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
inetetamab (6)
ASLAN001 (6)
BDTX-189 (5)
AEE788 (4)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
MET306 (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
sunvozertinib (3)
AST-301 (2)
Bay846 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
sevabertinib (1)
IAH0968 (1)
MP0274 (1)
(1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
RT1978 (1)
ABL105 (1)
RG6596 (1)
KD019 (1)
IMM2902 (1)
ABT-101 (0)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
BMS690514 (0)
CAM-H2 (0)
CAT-179 (0)
CUDC-101 (0)
DA 3111 (trastuzumab biosimilar) (0)
(0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
(0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
JNJ-26483327 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MP412 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
(0)
Sym013 (0)
TAC100-HER2 (0)
TAK-285 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
AST1306 (0)
cipatinib (0)
dHER2+AS15 (0)
IBI315 (0)
KBP-5209 (0)
RG6194 (0)
AZD8931 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
mifamurtide (2)
RB-1355 (0)
LOAd703 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 overexpression
Solid Tumor
HER-2 overexpression
Solid Tumor
CT-0508
Sensitive: B - Late Trials
CT-0508
Sensitive
:
B
CT-0508
Sensitive: B - Late Trials
CT-0508
Sensitive
:
B
HER-2 positive
Solid Tumor
HER-2 positive
Solid Tumor
CT-0508
Sensitive: C2 – Inclusion Criteria
CT-0508
Sensitive
:
C2
CT-0508
Sensitive: C2 – Inclusion Criteria
CT-0508
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.